Skip to main content

Third vaccine could be approved for U.K. within weeks boosting mass immunisation drive, top scientist says

Johnson & Johnson's vaccine candidate, which is being developed by its Belgium-based division Janssen, could be approved for use by next month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.